Literature DB >> 32212768

Purpose-guided trial design in health-related behavioral intervention research.

Kenneth E Freedland1.   

Abstract

Purpose-guided trial design (PGTD) is a novel heuristic framework for planning randomized controlled trials of health-related behavioral interventions. Its use helps to ensure that the study design and the control or comparison group are compatible with the primary purpose of the trial. When used in conjunction with the recently developed pragmatic model for comparator selection in health-related behavioral trials (Freedland et al., 2019), the PGTD framework can help to resolve uncertainties, disagreements, and controversies about the comparators that are used in behavioral randomized controlled trials. For example, PGTD can help to answer questions about whether, when, and how to control for attention in behavioral trials. The PGTD framework can be used to evaluate published trials, but it is primarily intended for use as a behavioral trial planning tool. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Year:  2020        PMID: 32212768     DOI: 10.1037/hea0000867

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  3 in total

Review 1.  Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.

Authors:  Jacob S Aday; Boris D Heifets; Steven D Pratscher; Ellen Bradley; Raymond Rosen; Joshua D Woolley
Journal:  Psychopharmacology (Berl)       Date:  2022-04-01       Impact factor: 4.530

Review 2.  Designing Psychosocial Intervention Pilot Studies: A Tutorial for Palliative Care Investigators.

Authors:  Joseph G Winger; Sarah A Kelleher; Hannah M Fisher; Tamara J Somers; Gregory P Samsa
Journal:  J Pain Symptom Manage       Date:  2022-02-27       Impact factor: 5.576

3.  Fund behavioral science like the frameworks we endorse: the case for increased funding of preliminary studies by the National Institutes of Health.

Authors:  Michael W Beets; Christopher Pfledderer; Lauren von Klinggraeff; Sarah Burkart; Bridget Armstrong
Journal:  Pilot Feasibility Stud       Date:  2022-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.